J
Jiahui Chen
Researcher at Michigan State University
Publications - 41
Citations - 3397
Jiahui Chen is an academic researcher from Michigan State University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 13, co-authored 29 publications receiving 1519 citations. Previous affiliations of Jiahui Chen include Southern Methodist University.
Papers
More filters
Journal ArticleDOI
Improvements to the APBS biomolecular solvation software suite
Elizabeth Jurrus,Dave Engel,Keith T. Star,Kyle E. Monson,Juan Brandi,Lisa E. Felberg,David H. Brookes,Leighton Wilson,Jiahui Chen,Karina Liles,Minju Chun,Peter Li,David W. Gohara,Todd J. Dolinsky,Robert Konecny,David Ryan Koes,Jens Erik Nielsen,Teresa Head-Gordon,Weihua Geng,Robert Krasny,Guo-Wei Wei,Michael Holst,J. Andrew McCammon,Nathan A. Baker +23 more
TL;DR: The Adaptive Poisson-Boltzmann Solver (APBS) as mentioned in this paper was developed to solve the equations of continuum electrostatics for large biomolecular assemblages that has provided impact in the study of a broad range of chemical, biological, and biomedical applications.
Journal ArticleDOI
Improvements to the APBS biomolecular solvation software suite.
Elizabeth Jurrus,Dave Engel,Keith T. Star,Kyle E. Monson,Juan Brandi,Lisa E. Felberg,David H. Brookes,Leighton Wilson,Jiahui Chen,Karina Liles,Minju Chun,Peter Li,David W. Gohara,Todd J. Dolinsky,Robert Konecny,David Ryan Koes,Jens Erik Nielsen,Teresa Head-Gordon,Weihua Geng,Robert Krasny,Guo-Wei Wei,Michael Holst,J. Andrew McCammon,Nathan A. Baker +23 more
TL;DR: The Adaptive Poisson-Boltzmann Solver (APBS) as mentioned in this paper was developed to solve the equations of continuum electrostatics for large biomolecular assemblages that have provided impact in the study of a broad range of chemical, biological and biomedical applications.
Journal ArticleDOI
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
TL;DR: An artificial intelligence model, which has been trained with tens of thousands of experimental data and extensively validated by experimental results on SARS-CoV-2, reveals that Omicron may be over 10 times more contagious than the original virus or about 2.8 times as infectious as the Delta variant.
Journal ArticleDOI
Mutations Strengthened SARS-CoV-2 Infectivity.
TL;DR: It is shown that most likely future mutations will make SARS-CoV-2 more infectious, and it is predicted that a few residues on the receptor-binding motif (RBM) have high chances to mutate into significantly more infectious COVID-19 strains.
Journal ArticleDOI
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries.
TL;DR: Wang et al. as mentioned in this paper carried out a large-scale study of 506,768 SARS-CoV-2 genome isolates from patients to identify many other rapidly growing mutations on the spike (S) protein receptor-binding domain (RBD).